About Valence Labs
Valence Labs is a company based in Montreal (Canada) founded in 2017 by Therence Bois was acquired by Recursion in May 2023. Valence Labs has raised $8.5 million across 3 funding rounds from investors including Recursion Pharmaceuticals, Fundica and Fifty Years. Valence Labs operates in a competitive market with competitors including Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
- Headquarter Montreal, Canada
- Founders Therence Bois
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Valence Discovery Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.5 M (USD)
in 3 rounds
-
Latest Funding Round
$8.5 M (USD), Seed
Dec 15, 2021
-
Investors
Recursion Pharmaceuticals
& 7 more
-
Employee Count
Not available
-
Acquired by
Recursion
(May 08, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Valence Labs
Valence Labs has successfully raised a total of $8.5M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $8.5 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Valence Labs
Valence Labs has secured backing from 8 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Recursion Pharmaceuticals, Fundica and Fifty Years.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital firm investing in AI & life science sectors
|
Locked | Locked | Locked | |
|
Venture capital investments are made in precision medicine companies.
|
Locked | Locked | Locked |
Investor details for Valence Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Valence Labs
Investment portfolio details for Valence Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Valence Labs
Detailed financials for Valence Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Valence Labs Comparisons
Peer comparison for Valence Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Valence Labs
Valence Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Metaphore, Panakeia and Evolved By Nature, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| Locked | Locked | Locked |
Developer of drugs to treat various diseases
|
|
| Locked | Locked | Locked |
Provider of machine language and computational platform for drug discovery
|
|
| Locked | Locked | Locked |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| Locked | Locked | Locked |
Digital technology for biomedicinal molecule development in research is utilized.
|
|
| Locked | Locked | Locked |
Provider of software solutions for molecular diagnostics and discovery
|
Detailed competitors of Valence Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Valence Labs
Complete news archive for Valence Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valence Labs
Valence Labs was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Valence Labs is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
Valence Labs is a funded company, having raised a total of $8.5M across 3 funding rounds to date.
Valence Labs was established in 2017 in Montreal, Canada, as a research and productization unit within Recursion. Focus is placed on applying artificial intelligence to drug discovery processes. Computational methods are utilized to support advancements in healthcare, while open science initiatives and academic collaborations are encouraged. Operations center on developing tools and models for pharmaceutical innovation in the biotech sector.
Valence Labs has 8 investors. Key investors include Recursion Pharmaceuticals, Fundica, Fifty Years, Air Street Capital, and Amplitude Ventures.